$13.72+0.01|(+0.07%)
52W H: 13.78552W L: 5.69Beta: 1.50

About Organon & Co

Frequently Asked Questions

What is the 52-week range for OGN?

The 52-week high is $13.785 and the 52-week low is $5.69.

What is the P/E ratio for OGN?

The Price to Earnings (P/E) ratio is 17.24.

What is the dividend yield for OGN?

The indicated annual dividend yield is 9.86%.

What is the Return on Equity (ROE)?

The trailing twelve months (TTM) Return on Equity is 23.44%.

What is the Net Profit Margin?

The Net Profit Margin (TTM) is 3.41%.

What is the Price to Book (P/B) Ratio?

The annual Price to Book ratio stands at 2.48.

Analyst Recommendation Trends

Wall Street analyst consensus for OGN over the last few months:

2026-09-01
Buy: 0
S.Buy: 0
Hold: 7
Sell: 5
2026-08-01
Buy: 0
S.Buy: 0
Hold: 7
Sell: 5
2026-07-01
Buy: 0
S.Buy: 0
Hold: 7
Sell: 5
2026-06-01
Buy: 0
S.Buy: 0
Hold: 7
Sell: 5

Latest OGN News

Here is What to Know Beyond Why Organon & Co. (OGN) is a Trending Stock

Organon (OGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Yahoo10/2/2026

Organon to Present New Real-World Analysis of VTAMA® (tapinarof) Cream, 1%, at the 2026 Fall Clinical Dermatology Conference

JERSEY CITY, N.J., October 01, 2026--Organon to unveil first large-scale real-world effectiveness analyses of VTAMA (tapinarof) cream, 1% in patients with eczema at Fall Clinical.

Yahoo10/1/2026

Organon Canada announces the Approval and Availability of NDUVRA® (tapinarof cream), 1%, a New Steroid-Free Topical Treatment for Moderate to Severe Atopic Dermatitis in Adult and Pediatric Patients 2 Years of Age and Older

Organon Canada, a global healthcare company, today announces the approval and availability of NDUVRA® (tapinarof cream), 1%, for the topical treatment of moderate to severe atopic dermatitis in adult and pediatric patients 2 years of age and older.

Yahoo9/28/2026

Organon Canada Announces Availability Of NDUVRA To Treat Moderate To Severe Atopic Dermatitis

Organon Canada, a global healthcare company, today announces the approval and availability of NDUVRA® (tapinarof cream), 1%, for the topical treatment of moderate to severe atopic dermatitis in adult and pediatric

Benzinga9/28/2026

Why Organon (OGN) Is Getting Attention Today

Why MIUDELLA’s FDA review matters for Organon stock Organon (OGN) just picked up fresh attention after the FDA accepted a supplemental application to extend use of MIUDELLA, a copper IUD that Organon licensed globally earlier this year. The device is already indicated for pregnancy prevention for up to 3 years, with an extended duration review underway and commercial availability targeted for late 2026. For investors watching Organon stock, this product sits squarely in the women’s health...

Yahoo9/22/2026

Organon (OGN) Wins FDA Review Acceptance For Its Hormone Free Contraceptive Device

Organon (NYSE: OGN) received FDA acceptance to review a supplemental New Drug Application for its hormone free contraceptive device MIUDELLA. The company entered an exclusive global licensing agreement for MIUDELLA, aiming to expand access to hormone free contraception across markets. Organon plans commercial availability of MIUDELLA as a longer duration contraceptive option, subject to regulatory review outcomes and launch execution. Beyond the MIUDELLA sNDA review and new global license,...

Yahoo9/22/2026

Is Trending Stock Organon & Co. (OGN) a Buy Now?

Organon (OGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Yahoo9/21/2026

PhaseV Appoints Biopharma Leaders Klaus Beck and Avi Kulkarni to Scientific Advisory Board to Guide Expansion of AI Conductor

PhaseV, a leader in machine learning for clinical development, today announced the appointment of Klaus Beck, MD, PhD, PhD, former Chief Medical Officer of Organon, and Avi Kulkarni, PhD, MBA, CEO of InoRx, to its Scientific Advisory Board.

Yahoo9/16/2026

Organon Announces US FDA Has Accepted for Review a Supplemental New Drug Application for MIUDELLA®, a Hormone-Free Intrauterine Device

JERSEY CITY, N.J., September 14, 2026--Organon announces FDA accepts MIUDELLA® sNDA for review, seeking to extend approved hormone-free IUD use from 3 to 6 years in the U.S.

Yahoo9/14/2026

The Surprising Pockmarks On Cooper's Earnings That Caused Its Stock To Dive

Investors hammered Cooper Companies on Thursday after the medtech's fiscal third-quarter sales lagged Wall Street's expectations.

Yahoo9/10/2026

Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know

Zacks.com users have recently been watching Organon (OGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Yahoo9/8/2026

Related Stocks (Peers)

Companies operating in similar sectors to OGN:

Recent Insider Transactions

DateNameShares ChangedPriceValue
2026-08-11Arjona Ferreira Juan Camilo+11,519--
2026-08-11Arjona Ferreira Juan Camilo-4,134$13.62$56,305
2026-08-11Arjona Ferreira Juan Camilo+11,519--
2026-08-05Drinane Juliana Papa-14,761$13.57$200,307
2026-06-12Ozuah Philip+17,857$13.44$239,998
2026-06-12Leone Deborah R+17,857$13.44$239,998
2026-06-12Sequeira Ramona+17,857$13.44$239,998
2026-06-12Ezekowitz Alan+17,857$13.44$239,998
2026-06-12Patton Cynthia M+17,857$13.44$239,998
2026-06-12Gayle Helene D+17,857$13.44$239,998
2026-06-12Sharp Shalini+17,857$13.44$239,998
2026-06-12ESSNER ROBERT+17,857$13.44$239,998
2026-06-12LAZARUS ROCHELLE B+17,857$13.44$239,998
2026-05-06Holzbaur Lynette-26,448$13.3498$353,076
2026-05-06Holzbaur Lynette+46--
2026-05-06Holzbaur Lynette+26,448$13.3498$353,076
2026-03-31Drinane Juliana Papa-10,073--
2026-03-31Drinane Juliana Papa-6,378--
2026-03-31Drinane Juliana Papa+125,208--
2026-03-31Drinane Juliana Papa-3,451$5.7$19,671
2026-03-31Drinane Juliana Papa+10,073--
2026-03-31Drinane Juliana Papa-2,185$5.7$12,455
2026-03-31Drinane Juliana Papa+6,378--
2026-03-31Falcione Aaron-11,193--
2026-03-31Falcione Aaron-6,732--
2026-03-31Falcione Aaron+166,944--
2026-03-31Falcione Aaron-3,834$5.7$21,854
2026-03-31Falcione Aaron+11,193--
2026-03-31Falcione Aaron-2,306$5.7$13,144
2026-03-31Falcione Aaron+6,732--
2026-03-31Weaver Kirke-12,312--
2026-03-31Weaver Kirke-6,201--
2026-03-31Weaver Kirke+183,639--
2026-03-31Weaver Kirke-3,508$5.7$19,996
2026-03-31Weaver Kirke+12,312--
2026-03-31Weaver Kirke-1,767$5.7$10,072
2026-03-31Weaver Kirke+6,201--
2026-03-31Nisita Vittorio-8,394--
2026-03-31Nisita Vittorio-4,606--
2026-03-31Nisita Vittorio+125,208--
2026-03-31Nisita Vittorio-2,875$5.7$16,388
2026-03-31Nisita Vittorio+8,394--
2026-03-31Nisita Vittorio-1,578$5.7$8,995
2026-03-31Nisita Vittorio+4,606--
2026-03-31Holzbaur Lynette-6,715--
2026-03-31Holzbaur Lynette-4,252--
2026-03-31Holzbaur Lynette+41,736--
2026-03-31Holzbaur Lynette+75,125--
2026-03-31Holzbaur Lynette-1,914$5.7$10,910
2026-03-31Holzbaur Lynette+6,715--
2026-03-31Holzbaur Lynette-1,212$5.7$6,908
2026-03-31Holzbaur Lynette+4,252--
2026-03-31Morrissey Joseph T. Jr.-16,789--
2026-03-31Morrissey Joseph T. Jr.-7,795--
2026-03-31Morrissey Joseph T. Jr.+333,889--
2026-03-31Morrissey Joseph T. Jr.-4,784$5.7$27,269
2026-03-31Morrissey Joseph T. Jr.+16,789--
2026-03-31Morrissey Joseph T. Jr.-2,221$5.7$12,660
2026-03-31Morrissey Joseph T. Jr.+7,795--
2026-03-31Karp Daniel-6,715--
2026-03-31Karp Daniel-11,338--
2026-03-31Karp Daniel+100,166--
2026-03-31Karp Daniel-2,105$5.7$11,999
2026-03-31Karp Daniel+6,715--
2026-03-31Karp Daniel-3,554$5.7$20,258
2026-03-31Karp Daniel+11,338--
2026-03-31Arjona Ferreira Juan Camilo-13,431--
2026-03-31Arjona Ferreira Juan Camilo+200,333--
2026-03-31Arjona Ferreira Juan Camilo-4,820$5.7$27,474
2026-03-31Arjona Ferreira Juan Camilo+13,431--
2026-03-31Stahler Rachel A-12,312--
2026-03-31Stahler Rachel A-6,555--
2026-03-31Stahler Rachel A+183,639--
2026-03-31Stahler Rachel A-4,217$5.7$24,037
2026-03-31Stahler Rachel A+12,312--
2026-03-31Stahler Rachel A-2,246$5.7$12,802
2026-03-31Stahler Rachel A+6,555--
2026-03-31WALSH MATTHEW M-21,546--
2026-03-31WALSH MATTHEW M-12,047--
2026-03-31WALSH MATTHEW M+83,472--
2026-03-31WALSH MATTHEW M+321,368--
2026-03-31WALSH MATTHEW M-7,380$5.7$42,066
2026-03-31WALSH MATTHEW M+21,546--
2026-03-31WALSH MATTHEW M-4,127$5.7$23,524
2026-03-31WALSH MATTHEW M+12,047--
2026-03-29Holzbaur Lynette-5,319--
2026-03-29Holzbaur Lynette-1,516$5.84$8,853
2026-03-29Holzbaur Lynette+5,319--
2026-03-29Drinane Juliana Papa-7,979--
2026-03-29Drinane Juliana Papa-2,733$5.84$15,961
2026-03-29Drinane Juliana Papa+7,979--
2026-03-29Falcione Aaron-8,422--
2026-03-29Falcione Aaron-2,885$5.84$16,848
2026-03-29Falcione Aaron+8,422--
2026-03-29Arjona Ferreira Juan Camilo-8,865--
2026-03-29Arjona Ferreira Juan Camilo-3,181$5.84$18,577
2026-03-29Arjona Ferreira Juan Camilo+8,865--
2026-03-29Weaver Kirke-7,757--
2026-03-29Weaver Kirke-2,210$5.84$12,906
2026-03-29Weaver Kirke+7,757--
2026-03-29Nisita Vittorio-5,762--
2026-03-29Nisita Vittorio-1,974$5.84$11,528
2026-03-29Nisita Vittorio+5,762--
2026-03-29Morrissey Joseph T. Jr.-9,752--
2026-03-29Morrissey Joseph T. Jr.-2,779$5.84$16,229
2026-03-29Morrissey Joseph T. Jr.+9,752--
2026-03-29Karp Daniel-14,184--
2026-03-29Karp Daniel-4,446$5.84$25,965
2026-03-29Karp Daniel+14,184--
2026-03-29Stahler Rachel A-8,200--
2026-03-29Stahler Rachel A-2,809$5.84$16,405
2026-03-29Stahler Rachel A+8,200--
2026-03-29WALSH MATTHEW M-15,071--
2026-03-29WALSH MATTHEW M-5,162$5.84$30,146
2026-03-29WALSH MATTHEW M+15,071--
2026-02-27Falcione Aaron-2,301$7.23$16,636
2026-02-27Falcione Aaron+6,717--
2026-02-27Falcione Aaron-8,705$7.17$62,415
2026-02-27Falcione Aaron+23,805--
2026-02-27Nisita Vittorio-1,575$7.23$11,387
2026-02-27Nisita Vittorio+4,596--
2026-02-27Nisita Vittorio-6,210$7.17$44,526
2026-02-27Nisita Vittorio+16,287--
2026-02-27Weaver Kirke-1,763$7.23$12,746
2026-02-27Weaver Kirke+6,186--
2026-02-27Weaver Kirke-6,815$7.17$48,864
2026-02-27Weaver Kirke+21,925--
2026-02-27Morrissey Joseph T. Jr.-2,216$7.23$16,022
2026-02-27Morrissey Joseph T. Jr.+7,777--
2026-02-27Morrissey Joseph T. Jr.-8,054$7.17$57,747
2026-02-27Morrissey Joseph T. Jr.+27,564--
2026-02-27Stahler Rachel A-2,240$7.23$16,195
2026-02-27Stahler Rachel A+6,540--
2026-02-27Stahler Rachel A-8,475$7.17$60,766
2026-02-27Stahler Rachel A+23,178--
2026-02-27WALSH MATTHEW M-4,117$7.23$29,766
2026-02-27WALSH MATTHEW M+12,020--
2026-02-27WALSH MATTHEW M-14,887$7.17$106,740
2026-02-27WALSH MATTHEW M+42,599--
2025-11-13Drinane Juliana Papa+65,616--
2025-11-13Morrissey Joseph T. Jr.+131,233--
2025-11-12COX CARRIE SMITH+65,400$7.6721$501,755
2025-11-07Drinane Juliana Papa-1,242$6.71$8,334
2025-11-07Drinane Juliana Papa+3,626--
2025-11-07Drinane Juliana Papa+1,242$6.71$8,334
2025-11-07Drinane Juliana Papa+3,626--
2025-11-07Holzbaur Lynette-2,417--
2025-11-07Holzbaur Lynette-689$6.71$4,623
2025-11-07Holzbaur Lynette+2,417--
2025-11-07Arjona Ferreira Juan Camilo-6,446--
2025-11-07Arjona Ferreira Juan Camilo-2,307$6.71$15,480
2025-11-07Arjona Ferreira Juan Camilo+6,446--
2025-11-05Holzbaur Lynette-3,037--
2025-11-05Holzbaur Lynette-866$6.52$5,646
2025-11-05Holzbaur Lynette+3,037--